VeevaChinaCRMSuite: A Digital Engine Empowering Commercial Excellence for Chinese Pharmaceutical Companies

VeevaChinaCRMSuite: A Digital Engine Empowering Commercial Excellence for Chinese Pharmaceutical CompaniesIn the current phase, accelerating digital innovation, adopting advanced technologies, and building efficient digital systems to achieve the goal of double improvement in efficiency and effectiveness ("two rises") and cost reduction ("one decline") has become a core strategy in pharmaceutical commercial operations. To assist Chinese pharmaceutical companies in achieving this goal, Veeva Systems, a leading cloud software provider for the life sciences industry, announced the renaming of its new generation commercial excellence marketing platform, VeevaChinaSFA, to "VeevaChinaCRMSuite" at the "2024 Veeva China Business Summit" on October 24th

VeevaChinaCRMSuite: A Digital Engine Empowering Commercial Excellence for Chinese Pharmaceutical Companies

In the current phase, accelerating digital innovation, adopting advanced technologies, and building efficient digital systems to achieve the goal of double improvement in efficiency and effectiveness ("two rises") and cost reduction ("one decline") has become a core strategy in pharmaceutical commercial operations. To assist Chinese pharmaceutical companies in achieving this goal, Veeva Systems, a leading cloud software provider for the life sciences industry, announced the renaming of its new generation commercial excellence marketing platform, VeevaChinaSFA, to "VeevaChinaCRMSuite" at the "2024 Veeva China Business Summit" on October 24th.

VeevaChinaCRMSuite is a powerful digital solution that is HCP (Healthcare Professional) centered. It provides a comprehensive one-stop digital management solution for commercial operations, covering advanced core CRM management, full-process meeting management, and multi-channel interaction management, based on the needs of the most important core business scenarios in pharmaceutical commercial marketing and promotion. The platform helps companies to manage the entire process of drug launch marketing in a compliant and digital way, empowering medical representatives, promoting collaboration between sales, marketing, and medical teams, and ultimately helping pharmaceutical companies achieve commercial excellence.

A Comprehensive Suite of Features to Meet Diverse Needs

VeevaChinaCRMSuite includes a series of localized product suites and solutions designed for the Chinese market, comprehensively meeting the broad and personalized commercialization needs of life sciences companies. Specifically, the platform includes:

• VeevaChinaCRM: A core CRM management system that provides powerful customer relationship management capabilities to help pharmaceutical companies effectively manage and maintain customer relationships.

• VeevaChinaEventsManagement: A full-process meeting management system that supports the management of offline and online meetings, improving meeting efficiency and effectiveness.

• VeevaChinaEngage (formerly RemoteMeeting): A multi-channel interaction management system that provides a wealth of interactive tools to help pharmaceutical companies build closer relationships with HCPs.

• VeevaApprovedWeChat (formerly RepTriggeredWeChat): A WeChat public account management tool that helps pharmaceutical companies use WeChat for information dissemination and interaction in a compliant manner.

• VeevaChinaCampaignManager: A marketing campaign management system that helps pharmaceutical companies plan, execute, and evaluate marketing campaigns to improve marketing effectiveness.

A Powerful Ecosystem for Synergistic Efficiency

In addition to its powerful feature suite, VeevaChinaCRMSuite leverages Veeva's comprehensive product ecosystem that spans the entire life sciences process and is global. It can interoperate with market-leading master data management services like VeevaOpenData and numerous system products within Veeva's global ecosystem (such as VeevaPromoMats, VeevaLink, etc.), unleashing the synergistic effects of the system. The platform can also interact with Veeva's global business cloud product innovations to help pharmaceutical companies achieve more efficient global unified management in their commercial operations, further accelerating innovation.

Real-World Application Results Showcase Platform Advantages

Currently, VeevaChinaCRMSuite has served over 40,000 end users at nearly 20 pharmaceutical companies, including several well-known global multinational corporations such as MSD, Merck, and Astellas, empowering their China local business growth and ensuring their global compliance and headquarters visibility. The platform delivers significant value to customers by simplifying business processes, enabling efficient cross-departmental collaboration, data-driven precise market marketing decisions, and improvements in operational efficiency and effectiveness while ensuring compliance.

"Software + Data + Consulting" Synergistic Efficiency, Comprehensive Empowerment

Veeva is actively building a closed-loop ecosystem of "software + data + consulting," leveraging data as the foundation, software as the engine, and consulting as the wings to provide pharmaceutical companies with all-round support from strategic planning to implementation. Integrating global leading software technology, rich industry data resources, and professional consulting services, Veeva helps pharmaceutical companies quickly respond to market changes, enhance competitiveness, accelerate new drug launches while ensuring compliance, and deliver faster, safer, and more effective treatment options to patients.

Continuous Innovation, Empowering the Development of China's Pharmaceutical Industry

Veeva's China business cloud solutions, through the synergistic efficiency of VeevaChinaCRMSuite, VeevaOpenData master data management services, and VeevaBusinessConsulting, will continue to empower pharmaceutical companies to enhance business value, increase customer engagement, achieve operational excellence and commercial success, and promote the digital transformation and sustainable development of China's pharmaceutical industry.

Damian Kelly, General Manager of Veeva Asia, said: "From the day we entered China, Veeva has adhered to its long-term commitment to the industry and the public. Faced with China's unique technology ecosystem and healthcare system, we continue to invest and continuously develop and enrich localized solutions to empower our customers' success and industry development."

Ding Xiaofeng, General Manager of Veeva China, said: "As an important step in the 'China Innovation 3.0' strategy, Veeva has officially renamed its VeevaChinaSFA product to VeevaChinaCRMSuite. This means that we will bring more and more rich CRM suite products and a more complete product ecosystem to our customers in China. At the same time, we will continue to build a closed-loop ecosystem of software, data, and consulting, better leverage AI, and help our customers reduce costs, increase efficiency, and create value."

The launch of VeevaChinaCRMSuite marks Veeva's continued deep cultivation of the Chinese market, using digital power to help Chinese pharmaceutical companies achieve commercial excellence, and drive the healthy development of China's pharmaceutical industry. In the future, Veeva will continue to adhere to the "customer first" philosophy, constantly innovate, provide higher quality digital solutions and services to Chinese pharmaceutical companies, jointly promote the digital transformation and upgrading of China's pharmaceutical industry, and achieve high-quality development.

Disclaimer: The content of this article is sourced from the internet. The copyright of the text, images, and other materials belongs to the original author. The platform reprints the materials for the purpose of conveying more information. The content of the article is for reference and learning only, and should not be used for commercial purposes. If it infringes on your legitimate rights and interests, please contact us promptly and we will handle it as soon as possible! We respect copyright and are committed to protecting it. Thank you for sharing.(Email:[email protected])